Short stature and body proportion in thalassaemia

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue SUPPL. 3, 1998, Pages 811-816

  Caruso Nicoletti, M ^a   De Sanctis, V ^b   Capra, M ^c   Cardinale, G ^d   Cuccia, L ^c   Di Gregorio, F ^a   Filosa, A ^e   Galati, M C ^f   Lauriola, A ^b   Malizia, R ^g   Mangiagli, A ^h   Massolo, F ⁱ   Mastrangelo, C ^j   Meo, A ^k   Messina, M F ^k   Ponzi, G ^d   Raiola, G ^f   Ruggiero, L ^l   Tamborino, G ^l   Saviano, A ^e  

^a UNIVERSITY OF CATANIA   (Italy)

^b S ANNA HOSPITAL   (Italy)

^c Children's Hospital   (Italy)

^d F Ferrari Hospital   (Italy)

^e CARDARELLI HOSPITAL   (Italy)

^f PUGLIESE CIACCIO HOSPITAL   (Italy)

^g Villa Sofia Hospital   (Italy)

^h Umberto I Hospital   (Italy)

ⁱ UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^j Department of Pediatrics ^*  (Italy)

^k UNIVERSITY OF MESSINA   (Italy)

^l Sacro Cuore di Gesù Hospital   (Italy)

more..

Author keywords

Body disproportion; Growth; Short stature; Short trunk; Thalassaemia

Indexed keywords

DEFEROXAMINE; FERRITIN;

ADOLESCENT; ADULT; ANTHROPOMETRY; BLOOD TRANSFUSION; BODY BUILD; BONE DYSPLASIA; BONE LESION; CHILD; CONFERENCE PAPER; FEMALE; GROWTH DISORDER; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; SHORT STATURE; SIDEROSIS; THALASSEMIA;

ADOLESCENT; ADULT; AGING; BETA-THALASSEMIA; BLOOD TRANSFUSION; BODY CONSTITUTION; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DEFEROXAMINE; FEMALE; FERRITINS; HUMANS; IRON CHELATING AGENTS; MALE;

EID: 0032437612     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Pantelakis S. Growth patterns in patients with thalassaemia major. Acta Paediatr 1994; Suppl 406: 109-110.
2. De Sanctis V, Katz M, Vullo C, Bagni B, Ughi M, Wonke B. Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major. Clin Endocrinol 1994; 40: 791-798.
3. De Sanctis V, Atti G, Banin P, Orzincolo C, Cavallini AR, Patti D, Vullo C. Growth in thalassaemia major. Acta Med Auxol 1991; 23: 29-36.
4. Brill PW, Winchester P, Giardina PI, Cunningham-Rundles S. Desferrioxamine induced bone dysplasia in patients with thalassaemia major. AJR 1991; 156: 561-565.
5. Olivieri NF, Koren G, Harris J, Khattak S, Freedman MH, Templeton D, Bailey JD, Reilly BJ. Growth failure and bony changes induced by desferrioxamine. Am J Pediatr Hematol/Oncol 1992; 14: 48-56.
6. Rodda CP, Reid ED, Johnson S, Doery J, Matthews R, Bowden DK. Short stature in homozygous beta-thalassaemia is due to disproportionate truncal shortening. Clin Endocrinol 1995; 42: 587-592.
7. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 1976: 51: 170-179.
8. De Sanctis V, Urso L. L'accrescimento staturale nella talassemia. Minerva Pediatr 1997; 49: 121-128.
9. Naselli A, Vignolo M, Di Battista E, Mattel R, Aicardi G. Spondylometaphyseal abnormalities and severe short stature in a deferoxamine-treated homozygous beta-thalassemia patient. Acta Med Auxol 1995; 27: 125-132.
10. De Sanctis V, Pinamonti A, Di Palma A, Sprocati M, Atti G, Gamborini MR, Vullo C. Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine. Eur J Pediatr 1996; 155: 368-372.
11. Borgna-Pignatti C, De Stefano P, Zonta L, Vullo C, De Sanctis V, Melevendi C, Naselli A, Masera G, Tarzoli S, Gabutti V. Growth and sexual maturation in thalassaemia major. J Pediatr 1985; 106: 150-155.
12. Kattamis C, Liakopoulou T, Kattamis A. Growth and development in children with thalassaemia major. Acta Paediatr Scand 1990; Suppl 366: 111-117.
13. De Sanctis V on behalf of the Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol 1995; 42: 581-588.